Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/spOD0FUMaF0/266971.php
Saturday, 5 October 2013
NIH grant could develop technology to help personalize leukemia treatments
People affected by leukemia and health care professionals who advocate for personalized medicine options could benefit from technology that is being developed with funding from a National Institutes of Health grant. Tymora Analytical Operations LLC, Purdue University and St. Jude Children's Research Hospital have been awarded a one-year, $300,000 Phase I STTR grant from the NIH. The groups will develop technology that could pinpoint the proteins inside cells affected by the disease so treatments can be more targeted...
No comments:
Post a Comment